Literature DB >> 16601740

Structural and functional outcome of scleral patch graft.

V S Sangwan1, V Jain, P Gupta.   

Abstract

PURPOSE: To evaluate the visual and structural outcomes of scleral patch grafting in cases of scleral defect.
METHODS: The study was a retrospective interventional case series. Medical records of all patients who underwent scleral patch grafting at a tertiary care centre between 1997 and 2003 for scleral defects were reviewed. After removal of all the devitalized tissue, alcohol-preserved full-thickness sclera was tailored to fit the defect and sutured in place. The graft was covered with a conjunctival flap or amniotic membrane. Structural integrity and visual outcome were assessed as the main outcome measures.
RESULTS: A total of 13 eyes of 13 patients required scleral patch grafting for scleral defects of varying aetiologies, the most common being necrotizing scleritis following pterygium surgery (40%). The patients were followed up for 6-60 months, an average period of 24.3 months. Tectonic success was achieved in 10 eyes (76.9%). Three complications were noted: endophthalmitis, graft necrosis, and graft dehiscence with uveal prolapse. However, no regrafts were needed. Epithelialization and vascularization were seen in the remaining eyes after an average duration of 3-4 weeks. Visual acuity remained stable in the majority (9/13, 60%), improved in one and deteriorated in three eyes.
CONCLUSIONS: Scleral grafting with overlying conjunctival or amniotic membrane graft is an effective and simple measure for preserving globe integrity both structurally and functionally.

Entities:  

Mesh:

Year:  2006        PMID: 16601740     DOI: 10.1038/sj.eye.6702344

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  17 in total

1.  Prophylactic removal and microbiological evaluation of calcified plaques after pterygium surgery.

Authors:  Tai Jun Kim; Hyuk Jin Choi; Mee Kum Kim; Won Ryang Wee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-15       Impact factor: 3.117

2.  Donor pericardium graft repair of traumatic globe rupture at previous trabeculectomy site.

Authors:  Brinda P Shah; Jonathan Clarke
Journal:  Digit J Ophthalmol       Date:  2014-08-31

3.  Management and outcome of microbial anterior scleritis.

Authors:  Matthew A Cunningham; Jamie K Alexander; Alice Y Matoba; Dan B Jones; Kirk R Wilhemus
Journal:  Cornea       Date:  2011-09       Impact factor: 2.651

4.  Treatment of exposed explants with donor sclera and amniotic membrane.

Authors:  Syed Khurshid Gibran; Nihal Kenawy; David Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-12       Impact factor: 3.535

5.  Preserved scleral patch graft for unexpected extreme scleral thinning found at the scleral buckling procedure: a case report.

Authors:  Spela Stunf; Xhevat Lumi; Brigita Drnovšek-Olup
Journal:  Indian J Ophthalmol       Date:  2011 May-Jun       Impact factor: 1.848

6.  Tectonic corneal graft for conjunctival rhinosporidiosis with scleral melt.

Authors:  Pushpa Jacob; Jeyanth S Rose; Abhishek Hoshing; Geeta Chacko
Journal:  Indian J Ophthalmol       Date:  2011 May-Jun       Impact factor: 1.848

7.  Use of an Autologous Lamellar Scleral Graft to Repair a Scleral Melt After Mitomycin Application.

Authors:  Nihat Polat
Journal:  Ophthalmol Ther       Date:  2014-11-22

8.  Tailored treatment for the management of scleral necrosis following pterygium excision.

Authors:  Linna Lu; Shiqiong Xu; Shengfang Ge; Chunyi Shao; Zi Wang; Xuyang Weng; Wenjuan Lu; Xinhua Wu; Yao Fu; Xianqun Fan
Journal:  Exp Ther Med       Date:  2017-01-12       Impact factor: 2.447

9.  Fungal scleritis masquerading as surgically induced necrotizing scleritis: a case report.

Authors:  Srikant Kumar Sahu; Sujata Das; Debabrata Sahani; Savitri Sharma
Journal:  J Med Case Rep       Date:  2013-12-30

10.  Cross-linking as an adjuvant treatment for tectonic corneal lamellar graft preparation.

Authors:  George D Kymionis; Argyro D Plaka; Vasilios F Diakonis; Michael A Grentzelos; Georgios A Kontadakis; Andreana C Mersinoglou; Efstathios T Detorakis; Fotis Topouzis
Journal:  Open Ophthalmol J       Date:  2013-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.